Sfoglia per AUTORE
RIBALDONE D
Collezione AOU Città della Salute di Torino

  

Items : 95

Increased prevalence of high-risk coronary plaques in metabolic dysfunction associated steatotic liver disease patients: A meta-analysis. in European journal of clinical investigation / Eur J Clin Invest. 2024 Sep;54(9):e14188. doi: 10.1111/eci.14188. Epub 2024 Feb 23.
2024
ASL Città di Torino
AOU Città della Salute di Torino

De Ferrari GM; D'Ascenzo F; Iannaccone M; Bugianesi E; Mennini G; Corradini SG; Mancone M; Zullino V; Bruno F; Gallone G; Armandi A; Birtolo LI; Nebiolo M; Gatti M; Ribaldone DG; De Filippo O; Di Pietro G;

Treatment of Antibiotic Refractory Chronic Pouchitis With JAK Inhibitors and S1P Receptor Modulators: An ECCO CONFER Multicentre Case Series. in Journal of Crohn's & colitis / J Crohns Colitis. 2024 May 31;18(5):720-726. doi: 10.1093/ecco-jcc/jjad194.
2024
AOU Città della Salute di Torino

Ribaldone DG; Testa G; Verstockt B; Molnar T; Savarino E; Schmidt C; Vieujean S; Teich N; Meianu C; Juillerat P; Grellier N; Lobaton T;

Helicobacter pylori in Inflammatory Bowel Diseases: Active Protagonist or Innocent Bystander? in Antibiotics (Basel, Switzerland) / Antibiotics (Basel). 2024 Mar 17;13(3):267. doi: 10.3390/antibiotics13030267.
2024
AOU Città della Salute di Torino

Bretto E; Frara S; Armandi A; Caviglia GP; Saracco GM; Bugianesi E; Pitoni D; Ribaldone DG;

Correlation between Polymorphisms of Vitamin D Metabolism Genes and Perianal Disease in Crohn's Disease. in Biomedicines / Biomedicines. 2024 Jan 30;12(2):320. doi: 10.3390/biomedicines12020320.
2024
ASL Città di Torino
AOU Città della Salute di Torino

Ribaldone DG; D'Avolio A; Saracco GM; Armandi A; Caviglia GP; Vernero M; Manca A; Palermiti A; Antonucci M; Cafasso C; Cusato J;

2024
AOU Città della Salute di Torino

Ribaldone DG; Nardi S; Chiarello L; Cicalini C; Scalvini D; Saibeni S; Vernero M; Bezzio C;

Hyper Mucinous Proliferations in the Mucosa of Patients with Inflammatory Bowel Disease: Histological Lesions with a Real Potential for Neoplastic Evolution? in Diagnostics (Basel, Switzerland) / Diagnostics (Basel). 2024 Feb 26;14(5):499. doi: 10.3390/diagnostics14050499.
2024
AOU Città della Salute di Torino

Canavese G; Ribaldone DG; Falco EC;

Inflammatory Bowel Disease and Irritable Bowel Syndrome: What Differences in Mentalization Abilities? A Scoping Review. in International journal of environmental research and public health / Int J Environ Res Public Health. 2023 Nov 30;20(23):7125. doi: 10.3390/ijerph20237125.
2023
AOU Città della Salute di Torino

Benfante A; Cisarò F; Ribaldone DG; Castelli L; Sandroni N; Romeo A;

Patients with inflammatory bowel disease are at increased risk of atherothrombotic disease: A systematic review with meta-analysis. in International journal of cardiology / Int J Cardiol. 2023 May 1;378:96-104. doi: 10.1016/j.ijcard.2023.02.042. Epub 2023 Mar 1.
2023
ASL Città di Torino
AOU Città della Salute di Torino

Ribaldone DG; Bugianesi E; Armandi A; De Ferrari GM; Bernstein CN; Caviglia GP; Giannino G; Testa G; De Filippo O; Bruno F; Iannaccone M; D'Ascenzo F;

Novelties on non-invasive biomarkers for the assessment of intestinal permeability and gut barrier integrity in patients with inflammatory bowel diseases. in Minerva gastroenterology / Minerva Gastroenterol (Torino). 2023 Mar;69(1):1-3. doi: 10.23736/S2724-5985.22.03215-6.
2023
AOU Città della Salute di Torino

Caviglia GP; Ribaldone DG; Fagoonee S;

2023
AO Ordine Mauriziano
AOU Città della Salute di Torino

Vineis P; Calvo PL; Bruno M; Astegiano M; Crocella L; Guiotto C; Stalla F; Francescato G; Grioni S; Sieri S; Caviglia GP; Zanatto L; Tarallo S; Pardini B; Francavilla A; Ferrero G; Ribaldone DG; Naccarati A;

Prevalence, Pathogenesis and Management of Anemia in Inflammatory Bowel Disease: An IG-IBD Multicenter, Prospective, and Observational Study. in Inflammatory bowel diseases / Inflamm Bowel Dis. 2023 Jan 5;29(1):76-84. doi: 10.1093/ibd/izac054.
2023
AOU Città della Salute di Torino
ASL Torino 3

Bergamaschi G; Castiglione F; D'Incà R; Astegiano M; Fries W; Milla M; Ciacci C; Rizzello F; Saibeni S; Ciccocioppo R; Orlando A; Bossa F; Principi M; Vernia P; Ricci C; Scribano ML; Bodini G; Mazzucco D; Bassotti G; Riegler G; Buda A; Neri M; Caprioli F; Monica F; Manca A; Villa E; Fiorino G; Comberlato M; Aronico N; et alii...

Epidemiology of Inflammatory Bowel Diseases: A Population Study in a Healthcare District of North-West Italy. in Journal of clinical medicine / J Clin Med. 2023 Jan 13;12(2):641. doi: 10.3390/jcm12020641.
2023
ASL Cuneo 2
AOU Città della Salute di Torino

Saracco GM; Astegiano M; Armandi A; Frara S; Tribocco E; Poshnjari A; Bretto E; Vanni R; Bertolino C; Garrone A; Caviglia GP; Bertolusso L; Ribaldone DG;

Cross-Sectional and Longitudinal Performance of Non-Invasive Tests of Liver Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease. in Journal of clinical medicine / J Clin Med. 2023 Jan 13;12(2):650. doi: 10.3390/jcm12020650.
2023
AOU Città della Salute di Torino

Armandi A; Rosso C; Younes R; Leeming DJ; Karsdal MA; Caviglia GP; Pérez-Diaz-Del-Campo N; D'Amato D; Abdulle A; Nicolosi A; Castelnuovo G; Saracco GM; Ribaldone DG; Bugianesi E;

The Histology-Driven Differential Diagnosis in Bowel Inflammatory Conditions Is Not All That Obvious: Evidence from a Survey Based on Digital Slides. in Diagnostics (Basel, Switzerland) / Diagnostics (Basel). 2023 Dec 18;13(24):3684. doi: 10.3390/diagnostics13243684.
2023
AOU Città della Salute di Torino

Canavese G; Falco EC; Perez-Diaz-Del-Campo N; Caviglia GP; Di Giovanni F; Ribaldone DG;

Inflammatory Bowel Disease: Emerging Therapies and Future Treatment Strategies. in Biomedicines / Biomedicines. 2023 Aug 11;11(8):2249. doi: 10.3390/biomedicines11082249.
2023
AOU Città della Salute di Torino

Bretto E; Ribaldone DG; Caviglia GP; Saracco GM; Bugianesi E; Frara S;

COVID-19 and the enteric system: rapidly propagating issues. in Minerva medica / Minerva Med. 2023 Apr;114(2):217-223. doi: 10.23736/S0026-4806.22.08077-6. Epub 2022 Mar 22.
2023
AOU Città della Salute di Torino

Actis GC; Pellicano R; Fagoonee S; Ribaldone DG; Actis GC; Pellicano R; Fagoonee S; Ribaldone DG;

Expression of SARS-Cov-2 Entry Factors in Patients with Chronic Hepatitis. in Viruses / Viruses. 2022 Oct 29;14(11):2397. doi: 10.3390/v14112397.
2022
AOU Città della Salute di Torino

Rosso C; Demelas C; Agostini G; Abate ML; Vernero M; Caviglia GP; D'Amato D; Armandi A; Tapparo M; Guariglia M; Troshina G; Massano A; Olivero A; Nicolosi A; Zannetti A; Pellicano R; Ciancio A; Saracco GM; Ribaldone DG; Bugianesi E; Fagoonee S;

Clinical Application of Droplet Digital PCR for Hepatitis Delta Virus Quantification. in Biomedicines / Biomedicines. 2022 Mar 29;10(4):792. doi: 10.3390/biomedicines10040792.
2022
AOU Città della Salute di Torino

Olivero A; Rosso C; Ciancio A; Abate ML; Nicolosi A; Troshina G; Armandi A; Ribaldone DG; Saracco GM; Bugianesi E; Rizzetto M; Caviglia GP;

2022
AOU Città della Salute di Torino

Caviglia GP; Nicolosi A; Abate ML; Carucci P; Rosso C; Rolle E; Armandi A; Aneli S; Olivero A; Risso A; Ribaldone DG; Fermer C; Saracco GM; Gaia S; Bugianesi E;

2022
AOU Città della Salute di Torino

Armandi A; Rosso C; Nicolosi A; Caviglia GP; Abate ML; Olivero A; D'Amato D; Vernero M; Gaggini M; Saracco GM; Ribaldone DG; Leeming DJ; Gastaldelli A; Bugianesi E;

2022
AOU Città della Salute di Torino

Gaia S; Rizza S; Bruno M; Ribaldone DG; Maletta F; Sacco M; Pacchioni D; Rizzi F; Saracco GM; Fagoonee S; De Angelis CG;

Effect of COVID-19 Pandemic on Hepatocellular Carcinoma Diagnosis: Results from a Tertiary Care Center in North-West Italy. in Current oncology (Toronto, Ont.) / Curr Oncol. 2022 Feb 24;29(3):1422-1429. doi: 10.3390/curroncol29030119.
2022
AOU Città della Salute di Torino

Ribaldone DG; Caviglia GP; Gaia S; Rolle E; Risso A; Campion D; Brunocilla PR; Saracco GM; Carucci P;

The recipe for the perfect inflammatory bowel disease nurse in a northern Italy tertiary IBD center: going beyond clinical care. in Minerva gastroenterology / Minerva Gastroenterol (Torino). 2022 Dec;68(4):375-377. doi: 10.23736/S2724-5985.22.03179-5. Epub 20
2022
AOU Città della Salute di Torino

Pellicano R; Astegiano M; Ribaldone DG; Vernero M;

Serum glypican-3 for the prediction of survival in patients with hepatocellular carcinoma. in Minerva gastroenterology / Minerva Gastroenterol (Torino). 2022 Dec;68(4):378-386. doi: 10.23736/S2724-5985.21.03006-0. Epub 20
2022
AOU Città della Salute di Torino

Saracco GM; Pellicano R; Fagoonee S; Carucci P; Ribaldone DG; Armandi A; Olivero A; Abate ML; Rolle E; Rosso C; Risso A; Gaia S; Nicolosi A; Bugianesi E; Caviglia GP;

Predictive Factors of Surgical Recurrence in Patients with Crohn's Disease on Long-Term Follow-Up: A Focus on Histology. in Journal of clinical medicine / J Clin Med. 2022 Aug 27;11(17):5043. doi: 10.3390/jcm11175043.
2022
AOU Città della Salute di Torino

Caviglia GP; Mineo CA; Rosso C; Armandi A; Astegiano M; Canavese G; Resegotti A; Saracco GM; Ribaldone DG;

Intestinal microbiota changes induced by TNF-inhibitors in IBD-related spondyloarthritis. in RMD open / RMD Open. 2021 Sep;7(3):e001755. doi: 10.1136/rmdopen-2021-001755.
2021
AOU Città della Salute di Torino

Ditto MC; Parisi S; Landolfi G; Borrelli R; Realmuto C; Finucci A; Caviglia GP; Ribaldone DG; Astegiano M; Zanetti A; Carrara G; Scirè CA; Antivalle M; Sarzi-Puttini P; Fusaro E;

2021
AOU Città della Salute di Torino

Caviglia GP; De Blasio F; Vernero M; Armandi A; Rosso C; Saracco GM; Bugianesi E; Astegiano M; Ribaldone DG;

2021
AOU Città della Salute di Torino

Caviglia GP; Armandi A; Rosso C; Gaia S; Aneli S; Rolle E; Abate ML; Olivero A; Nicolosi A; Guariglia M; Ribaldone DG; Carucci P; Saracco GM; Bugianesi E;

2021
AOU Città della Salute di Torino

Caviglia GP; Abate ML; Rolle E; Carucci P; Armandi A; Rosso C; Olivero A; Ribaldone DG; Tandoi F; Saracco GM; Ciancio A; Bugianesi E; Gaia S;

Inflammatory bowel disease course in liver transplant versus non-liver transplant patients for primary sclerosing cholangitis: LIVIBD, an IG-IBD study. in Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver / Dig Liver Dis. 2021 Jun;53(6):712-716. doi: 10.1016/j.dld.2020.09.011. Epub 2020 Sep 21.
2021
AOU Città della Salute di Torino

Romagnoli R; Saracco GM; Salizzoni M; Vecchi M; Milla M; Castiglione F; Sarli E; Reggio D; Boano V; Mosso E; Fagoonee S; Balestrieri P; De Blasio F; Furfaro F; Le Grazie M; Imperatore N; Ribaldone DG; Fiorino G; Astegiano M;

A Retrospective Experience of Helicobacter pylori Histology in a Large Sample of Subjects in Northern Italy. in Life (Basel, Switzerland) / Life (Basel). 2021 Jul 4;11(7):650. doi: 10.3390/life11070650.
2021
AOU Città della Salute di Torino

Ribaldone DG; Zurlo C; Fagoonee S; Rosso C; Armandi A; Caviglia GP; Saracco GM; Pellicano R;

Switching from Biosimilar to Biosimilar Adalimumab, Including Multiple Switching, in Crohn's Disease: A Prospective Study. in Journal of clinical medicine / J Clin Med. 2021 Jul 30;10(15):3387. doi: 10.3390/jcm10153387.
2021
AOU Città della Salute di Torino

Ribaldone DG; Tribocco E; Rosso C; Armandi A; Vernero M; Bugianesi E; Astegiano M; Saracco GM; Caviglia GP;

Risk Factors of Urothelial Cancer in Inflammatory Bowel Disease. in Journal of clinical medicine / J Clin Med. 2021 Jul 23;10(15):3257. doi: 10.3390/jcm10153257.
2021
AOU Città della Salute di Torino

Caviglia GP; Martini G; Armandi A; Rosso C; Vernero M; Bugianesi E; Astegiano M; Saracco GM; Ribaldone DG;

2021
AOU Città della Salute di Torino

Caviglia GP; Armandi A; Rosso C; Ribaldone DG; Pellicano R; Fagoonee S;

2021
AOU Città della Salute di Torino

Gaia S; Ciruolo M; Ribaldone DG; Rolle E; Migliore E; Mosso E; Vola S; Risso A; Fagoonee S; Saracco GM; Carucci P;

A randomized, double-blind, placebo-controlled pilot study to evaluate the efficacy and tolerability of a novel oral bioadhesive formulation for the treatment of nonerosive reflux disease-related symptoms. in European journal of gastroenterology & hepatology / Eur J Gastroenterol Hepatol. 2021 Feb 1;32(2):163-170. doi: 10.1097/MEG.0000000000001888.
2021
AOU Città della Salute di Torino

Ribaldone DG; Rajesh P; Chandradhara D; Astegiano M; Pellicano R;

Effectiveness and safety of switching to adalimumab biosimilar ABP 501 in Crohn's disease: the extrapolation concept. in Revista espanola de enfermedades digestivas / Rev Esp Enferm Dig. 2021 Feb;113(2):155. doi: 10.17235/reed.2020.7253/2020.
2021
AOU Città della Salute di Torino

Ribaldone DG; Vernero M; Astegiano M;

COVID-19: a user's guide, status of the art and an original proposal to terminate viral recurrence. in Minerva medica / Minerva Med. 2021 Feb;112(1):144-152. doi: 10.23736/S0026-4806.20.07054-8. Epub 2020 Oct 26.
2021
AOU Città della Salute di Torino

Pellicano R; Ribaldone DG; Fagoonee S; Actis GC;

Use of reflux finding score and reflux symptom index for the management of laryngo-pharyngeal lesions: a pilot study. in Minerva gastroenterology / Minerva Gastroenterol (Torino). 2021 Dec;67(4):406-408. doi: 10.23736/S2724-5985.21.02970-3. Epub 20
2021
AOU Città della Salute di Torino

Saracco GM; Ribaldone DG; Albera R; Spadola Bisetti M; Colombini J; Pellicano R;

Moving towards core antigen for the management of patients with overt and occult HBV infection. in Panminerva medica / Panminerva Med. 2021 Dec;63(4):499-507. doi: 10.23736/S0031-0808.20.04163-4. Epub 2020 Oct 19.
2021
AOU Città della Salute di Torino

Caviglia GP; Ribaldone DG; Rosso C; Armandi A;

Inflammatory Bowel Disease Nurse-Practical Messages. in Nursing reports (Pavia, Italy) / Nurs Rep. 2021 Apr 1;11(2):229-241. doi: 10.3390/nursrep11020023.
2021
AOU Città della Salute di Torino

Rosso C; Aaron AA; Armandi A; Caviglia GP; Vernero M; Saracco GM; Astegiano M; Bugianesi E; Ribaldone DG;

The Impact of Dysmetabolic Sarcopenia Among Insulin Sensitive Tissues: A Narrative Review. in Frontiers in endocrinology / Front Endocrinol (Lausanne). 2021 Nov 10;12:716533. doi: 10.3389/fendo.2021.716533. eCollection 2021
2021
AOU Città della Salute di Torino

Bugianesi E; Ribaldone DG; Caviglia GP; Rosso C; Armandi A;

Effect of COVID-19 pandemic on the workflow of endoscopy units: an international survey. in Therapeutic advances in gastroenterology / Therap Adv Gastroenterol. 2021 Apr 22;14:17562848211006678. doi: 10.1177/17562848211006678. eCollect
2021
AOU Città della Salute di Torino

Farkas K; Lukas M; Drobne D; Vavricka S; Kopylov U; Nancey S; Molander P; Ribaldone DG; Sacco M; Rutka M; Fábián A; Szántó K; Bor R; Resál T; Szepes Z; Molnár T;

Prognostic Role of Serum Cytokeratin-19 Fragment (CYFRA 21-1) in Patients with Hepatocellular Carcinoma. in Cancers / Cancers (Basel). 2020 Sep 28;12(10):2776. doi: 10.3390/cancers12102776.
2020
AOU Città della Salute di Torino

Caviglia GP; Ciruolo M; Olivero A; Carucci P; Rolle E; Rosso C; Abate ML; Risso A; Ribaldone DG; Tandoi F; Saracco GM; Bugianesi E; Gaia S;

Management of inflammatory bowel disease during COVID-19 pandemic. in Minerva gastroenterologica e dietologica / Minerva Gastroenterol Dietol. 2020 Sep;66(3):184-186. doi: 10.23736/S1121-421X.20.02707-5. Epub 2020
2020
AOU Città della Salute di Torino

Ribaldone DG; Astegiano M; Actis GC; Pellicano R; Ribaldone DG; Astegiano M; Actis GC; Pellicano R;

Proctitis: a glance beyond inflammatory bowel diseases. in Minerva gastroenterologica e dietologica / Minerva Gastroenterol Dietol. 2020 Sep;66(3):252-266. doi: 10.23736/S1121-421X.20.02670-7. Epub 2020
2020
AOU Città della Salute di Torino

Pellicano R; Saracco GM; Astegiano M; Morino M; Ribaldone DG; Mistrangelo M; Rizza S;

Differential diagnosis of pancreatic cysts: A prospective study on the role of intra-cystic glucose concentration. in Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver / Dig Liver Dis. 2020 Sep;52(9):1026-1032. doi: 10.1016/j.dld.2020.06.038. Epub 2020 Jul 13.
2020
AOU Città della Salute di Torino

Ribaldone DG; Bruno M; Gaia S; Cantamessa A; Bragoni A; Caropreso P; Sacco M; Fagoonee S; Saracco GM; De Angelis C; Ribaldone DG; Bruno M; Gaia S; Cantamessa A; Bragoni A; Caropreso P; Sacco M; Fagoonee S; Saracco GM; De Angelis C;

2020
AOU Città della Salute di Torino

Caviglia GP; Ciruolo M; Abate ML; Carucci P; Rolle E; Rosso C; Olivero A; Troshina G; Risso A; Nicolosi A; Ribaldone DG; Armandi A; Tandoi F; Saracco GM; Bugianesi E; Ciancio A; Gaia S;

Interplay between Oxidative Stress and Metabolic Derangements in Non-Alcoholic Fatty Liver Disease: The Role of Selenoprotein P. in International journal of molecular sciences / Int J Mol Sci. 2020 Nov 22;21(22):8838. doi: 10.3390/ijms21228838.
2020
AOU Città della Salute di Torino

Caviglia GP; Rosso C; Armandi A; Gaggini M; Carli F; Abate ML; Olivero A; Ribaldone DG; Saracco GM; Gastaldelli A; Bugianesi E;

Interstitial and Granulomatous Lung Disease in Inflammatory Bowel Disease Patients. in Journal of Crohn's & colitis / J Crohns Colitis. 2020 May 21;14(4):480-489. doi: 10.1093/ecco-jcc/jjz165.
2020
AOU Città della Salute di Torino

Eliadou E; Moleiro J; Ribaldone DG; Astegiano M; Rothfuss K; Taxonera C; Ghalim F; Carbonnel F; Verstockt B; Festa S; Maia L; Berrozpe A; Zagorowicz E; Savarino E; Ellul P; Vavricka SR; Calvo M; Koutroubakis I; Hoentjen F; Salazar LF; Callela F; Cañete Pizarro F; Soufleris K; Sonnenberg E; Cavicchi M; Wypych J; Hommel C; Ghiani A; Fiorino G; et alii...

2020
AOU Città della Salute di Torino

Caviglia GP; Rosso C; Stalla F; Rizzo M; Massano A; Abate ML; Olivero A; Armandi A; Vanni E; Younes R; Fagoonee S; Pellicano R; Astegiano M; Saracco GM; Bugianesi E; Ribaldone DG;

Effectiveness and safety of adalimumab biosimilar ABP 501 in Crohn's disease: an observational study. in Revista espanola de enfermedades digestivas / Rev Esp Enferm Dig. 2020 Mar;112(3):195-200. doi: 10.17235/reed.2020.6693/2019.
2020
AOU Città della Salute di Torino

Ribaldone DG; Caviglia GP; Pellicano R; Vernero M; Saracco GM; Morino M; Astegiano M;

Risk of incident melanoma in patients with inflammatory disease treated with anti-TNF: the Turin experience. in Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia / G Ital Dermatol Venereol. 2020 Jun;155(3):366-367. doi: 10.23736/S0392-0488.18.06017-0. Epub 2018 Se
2020
AOU Città della Salute di Torino

Pellicano R; Astegiano M; Ribaldone DG; Vernero M;

2020
AOU Città della Salute di Torino

Caviglia GP; Tucci A; Pellicano R; Fagoonee S; Rosso C; Abate ML; Olivero A; Armandi A; Vanni E; Saracco GM; Bugianesi E; Astegiano M; Ribaldone DG;

Vedolizumab for treatment of chronic refractory pouchitis: a systematic review with pool analysis. in Revista espanola de enfermedades digestivas / Rev Esp Enferm Dig. 2020 Jan;112(1):59-63. doi: 10.17235/reed.2019.6336/2019.
2020
AOU Città della Salute di Torino

Ribaldone DG; Pellicano R; Saracco GM; Morino M; Astegiano M;

2020
AOU Città della Salute di Torino

Vernero M; De Blasio F; Ribaldone DG; Bugianesi E; Pellicano R; Saracco GM; Astegiano M; Caviglia GP;

Analytical and clinical evaluation of a novel assay for anti-HBc IgG measurement in serum of subjects with overt and occult HBV infection. in Diagnostic microbiology and infectious disease / Diagn Microbiol Infect Dis. 2020 Apr;96(4):114985. doi: 10.1016/j.diagmicrobio.2020.114985. Epub 202
2020
AOU Città della Salute di Torino

Saracco GM; Romagnoli R; Rizzetto M; Smedile A; Ribaldone DG; Younes R; Abate ML; Rosso C; Troshina G; Tandoi F; Ciancio A; Olivero A; Caviglia GP; Bugianesi E;

Adalimumab Therapy Improves Intestinal Dysbiosis in Crohn's Disease. in Journal of clinical medicine / J Clin Med. 2019 Oct 9;8(10):1646. doi: 10.3390/jcm8101646.
2019
AOU Città della Salute di Torino

Ribaldone DG; Caviglia GP; Abdulle A; Pellicano R; Ditto MC; Morino M; Fusaro E; Saracco GM; Bugianesi E; Astegiano M;

Risk factors of suspected spondyloarthritis among inflammatory bowel disease patients. in Scandinavian journal of gastroenterology / Scand J Gastroenterol. 2019 Oct;54(10):1233-1236. doi: 10.1080/00365521.2019.1668052. Epub 2019 Sep
2019
AOU Città della Salute di Torino

Ribaldone DG; Vernero M; Parisi S; Ditto MC; Pellicano R; Morino M; Saracco GM; Fusaro E; Astegiano M;

The role of topical therapy for perianal fistulizing Crohn's disease: are we forgetting something? in Minerva gastroenterologica e dietologica / Minerva Gastroenterol Dietol. 2019 Jun;65(2):130-135. doi: 10.23736/S1121-421X.19.02565-0. Epub 2019
2019
AOU Città della Salute di Torino

Ribaldone DG; Resegotti A; Pellicano R; Astegiano M; Saracco GM; Morino M;

New Onset of Inflammatory Bowel Disease in Three Patients Undergoing IL-17A Inhibitor Secukinumab: A Case Series. in The American journal of gastroenterology / Am J Gastroenterol. 2019 Jan;114(1):179-180. doi: 10.1038/s41395-018-0422-z.
2019
AOU Città della Salute di Torino

Vernero M; Astegiano M; Ribaldone DG;

Apparent diffusion coefficient and enhancement patterns in MR imaging as markers of severe or moderate ileum inflammation in Crohn's disease. in Revista espanola de enfermedades digestivas / Rev Esp Enferm Dig. 2019 Jan;111(1):28-33. doi: 10.17235/reed.2018.5691/2018.
2019
AOU Città della Salute di Torino

Faletti R; Ribaldone DG; Gatti M; Perazzini C; Robella M; Angelino F; Saracco GM; Astegiano M; Pellicano R; Fonio P;

When is it useful to act on microbiota in atopic children? A recent experience. in Minerva pediatrica / Minerva Pediatr. 2019 Feb;71(1):1-3. doi: 10.23736/S0026-4946.18.05425-7.
2019
AOU Città della Salute di Torino

Ribaldone DG; Durazzo M; Cisarò F; Pellicano R;

The therapy of chronic pouchitis. in Minerva gastroenterologica e dietologica / Minerva Gastroenterol Dietol. 2019 Dec;65(4):265-267. doi: 10.23736/S1121-421X.18.02551-5. Epub 2019
2019
AOU Città della Salute di Torino

Astegiano M; Resegotti A; Ribaldone DG;

Correlation between Thiopurine S-Methyltransferase Genotype and Adverse Events in Inflammatory Bowel Disease Patients. in Medicina (Kaunas, Lithuania) / Medicina (Kaunas). 2019 Aug 5;55(8):441. doi: 10.3390/medicina55080441.
2019
ASL Città di Torino
AOU Città della Salute di Torino

Luzza F; D'Avolio A; Perri GD; Canaparo R; Pellicano R; Riganò D; Simiele M; Agnesod D; Nicolò A; Caviglia GP; Adriani A; Ribaldone DG; Saracco GM; Astegiano M;

Serum zonulin in patients with inflammatory bowel disease: a pilot study. in Minerva medica / Minerva Med. 2019 Apr;110(2):95-100. doi: 10.23736/S0026-4806.18.05787-7. Epub 2018 Aug 28.
2019
AOU Città della Salute di Torino

Saracco GM; Smedile A; Bresso F; Abate ML; Pellicano R; Rosso C; Dughera F; Ribaldone DG; Caviglia GP; Astegiano M; Caviglia GP; Dughera F; Ribaldone DG; Rosso C; Abate ML; Pellicano R; Bresso F; Smedile A; Saracco GM; Astegiano M;

Management of Helicobacter pylori in Piedmont, Italy. in Minerva gastroenterologica e dietologica / Minerva Gastroenterol Dietol. 2018 Sep;64(3):235-250. doi: 10.23736/S1121-421X.18.02483-2. Epub 2018
2018
AO Cuneo
ASL Torino 3
AO Ordine Mauriziano
AOU Città della Salute di Torino

Ribaldone DG; Simondi D; Rocca R; Caviglia GP; Fracchia M; Crocellà L; Lavagna A; Mazzucco D; Fagoonee S; Astegiano M; Ribaldone DG; Mazzucco D; Fagoonee S; Crocellà L; Lavagna A; Fracchia M; Caviglia GP; Simondi D; Rocca R; Astegiano M;

Is there a link between periampullary diverticula and biliopancreatic disease? An EUS approach to answer the question. in Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver / Dig Liver Dis. 2018 Sep;50(9):925-930. doi: 10.1016/j.dld.2018.07.034. Epub 2018 Aug 4.
2018
AO Cuneo
ASL Torino 4
AOU Città della Salute di Torino

De Angelis C; Strona S; Saracco GM; Risso A; Stradella D; Marietti M; Fasulo R; Gaia S; Ribaldone DG; Bruno M; Bruno M; Ribaldone DG; Fasulo R; Gaia S; Marietti M; Risso A; Stradella D; Strona S; Saracco GM; De Angelis C;

Severe ulcerative colitis: predictors of response and algorithm proposal for rescue therapy. in Irish journal of medical science / Ir J Med Sci. 2018 May;187(2):385-392. doi: 10.1007/s11845-017-1666-0. Epub 2017 Jul 29.
2018
AOU Città della Salute di Torino

Saracco G; Vernero M; Fagoonee S; Resegotti A; Pellicano R; Dileo I; Ribaldone DG; Astegiano M;

Helicobacter pylori eradication: poor medical compliance from East to West of the world. in Scandinavian journal of gastroenterology / Scand J Gastroenterol. 2018 Mar;53(3):265. doi: 10.1080/00365521.2018.1433231. Epub 2018 Jan 31.
2018
AOU Città della Salute di Torino

Ribaldone DG; Astegiano M; Pellicano R;

Fecal calprotectin: beyond intestinal organic diseases. in Panminerva medica / Panminerva Med. 2018 Mar;60(1):29-34. doi: 10.23736/S0031-0808.18.03405-5. Epub 2018 Jan 25.
2018
AOU Città della Salute di Torino

Caviglia GP; Ribaldone DG; Rosso C; Saracco GM; Astegiano M; Pellicano R;

Performance of protein induced by vitamin K absence or antagonist-II assessed by chemiluminescence enzyme immunoassay for hepatocellular carcinoma detection: a meta-analysis. in Scandinavian journal of gastroenterology / Scand J Gastroenterol. 2018 Jun;53(6):734-740. doi: 10.1080/00365521.2018.1459824. Epub 2018 Apr 18.
2018
AOU Città della Salute di Torino

Caviglia GP; Ribaldone DG; Abate ML; Ciancio A; Pellicano R; Smedile A; Saracco GM;

Letter: biologics treatment in Crohn's disease and risk of bowel resection-what about the patients who stop anti-TNF therapy? in Alimentary pharmacology & therapeutics / Aliment Pharmacol Ther. 2018 Jan;47(1):146-147. doi: 10.1111/apt.14321.
2018
AOU Città della Salute di Torino

Ribaldone DG; Saracco G; Astegiano M; Pellicano R;

Letter: therapeutic drug monitoring and inflammatory bowel disease-a call for an urgent standardization of the results. in Alimentary pharmacology & therapeutics / Aliment Pharmacol Ther. 2018 Feb;47(3):448-449. doi: 10.1111/apt.14456.
2018
AOU Città della Salute di Torino

Ribaldone DG; Saracco GM; Astegiano M; Pellicano R;

The adherence to the therapy in inflammatory bowel disease: beyond the number of the tablets. in Scandinavian journal of gastroenterology / Scand J Gastroenterol. 2018 Feb;53(2):141-146. doi: 10.1080/00365521.2017.1405070. Epub 2017 Dec 11.
2018
AOU Città della Salute di Torino

Caviglia GP; Finocchiaro F; Pellicano R; Saracco GM; Vernero M; Ribaldone DG; Astegiano M;

Significant improvement of glycemic control in diabetic patients with HCV infection responding to direct-acting antiviral agents. in Journal of medical virology / J Med Virol. 2018 Feb;90(2):320-327. doi: 10.1002/jmv.24954. Epub 2017 Nov 14.
2018
AOU Città della Salute di Torino

Smedile A; Bugianesi E; Ribaldone D; Terzi di Bergamo L; Giordanino C; Gallo M; Bianco Mauthe Degerfeld AGF; Fassio G; Vogliotti E; Sacco M; Pellegrini M; Bosio R; Bo S; Ciancio A; Rizzetto M; Saracco GM;

Gastroenterology today: between certainties and news. in Minerva gastroenterologica e dietologica / Minerva Gastroenterol Dietol. 2018 Dec;64(4):323-332. doi: 10.23736/S1121-421X.18.02465-0. Epub 2018
2018
ASL Asti
AOU Città della Salute di Torino

Saracco GM; Grassini M; Arrigoni A; Spandre M; Morgando A; Dughera L; Battaglia E; Astegiano M; Mégraud F; Ribaldone DG; Pellicano R; Pellicano R; Ribaldone DG; Astegiano M; Dughera L; Battaglia E; Morgando A; Arrigoni A; Spandre M; Grassini M; Saracco GM; Mégraud F;

Management of Pt1 tumours removed by endoscopy during colorectal cancer screening: Outcome and treatment quality indicators. in European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology / Eur J Surg Oncol. 2018 Dec;44(12):1873-1879. doi: 10.1016/j.ejso.2018.09.009. Epub 2018 Oct 16.
2018
AO Ordine Mauriziano
AOU Città della Salute di Torino

Segnan N; Silvani M; Fracchia M; Arrigoni A; Cassoni P; Ciancio A; Ribaldone DG; Giovo I; Senore C; Saracco GM; Senore C; Giovo I; Ribaldone DG; Ciancio A; Cassoni P; Arrigoni A; Fracchia M; Silvani M; Segnan N; Saracco GM;

How ameliorate the adherence in patients with inflammatory bowel disease? in Scandinavian journal of gastroenterology / Scand J Gastroenterol. 2018 Aug;53(8):938-939. doi: 10.1080/00365521.2018.1485731. Epub 2018 Jul 3.
2018
AOU Città della Salute di Torino

Ribaldone DG; Vernero M; Astegiano M; Pellicano R; Ribaldone DG; Vernero M; Astegiano M; Pellicano R;

Comment #2 on "First-Line Helicobacter pylori Eradication with Vonoprazan, Clarithromycin, and Metronidazole in Patients Allergic to Penicillin". in Gastroenterology research and practice / Gastroenterol Res Pract. 2018 Dec 16;2018:5260358. doi: 10.1155/2018/5260358. eCollection 2018.
2018
AOU Città della Salute di Torino

Astegiano M; Ribaldone DG; Ribaldone DG; Astegiano M;

The role of hepatic enzymes in Crohn's disease. in International journal of colorectal disease / Int J Colorectal Dis. 2017 Sep;32(9):1363-1364. doi: 10.1007/s00384-017-2829-1. Epub 2017 May 4.
2017
AOU Città della Salute di Torino

Pellicano R; Astegiano M; Ribaldone DG;

Does Helicobacter pylori infection increase the risk of adult-onset asthma? in European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology / Eur J Clin Microbiol Infect Dis. 2017 Oct;36(10):1995-1996. doi: 10.1007/s10096-017-3004-x. Epub 201
2017
AOU Città della Salute di Torino

Ribaldone DG; Saracco G; Pellicano R; Ribaldone DG; Saracco G; Pellicano R;

Features of inflammatory bowel disease followed in a second level center in Northern Italy. in Minerva medica / Minerva Med. 2017 Oct;108(5):481-482. doi: 10.23736/S0026-4806.17.05118-7.
2017
AOU Città della Salute di Torino

Ribaldone DG; Simondi D; Manca A; Demarchi B; Pulitanò R; Astegiano M; Pellicano R;

Finally, it is bismuth's time. in Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association / Saudi J Gastroenterol. 2017 Mar-Apr;23(2):127. doi: 10.4103/sjg.SJG_605_16.
2017
AOU Città della Salute di Torino

Ribaldone DG; Saracco G; Pellicano R;

Comment on Helicobacter pylori seroprevalence and the occurrence and severity of psoriasis. in Anais brasileiros de dermatologia / An Bras Dermatol. 2017 Jul-Aug;92(4):584. doi: 10.1590/abd1806-4841.2017112.
2017
AOU Città della Salute di Torino

Ribaldone DG; Saracco G; Pellicano R;

Biosimilar CT-P13 in treating ulcerative colitis in the real world. in Minerva gastroenterologica e dietologica / Minerva Gastroenterol Dietol. 2017 Dec;63(4):305-306. doi: 10.23736/S1121-421X.17.02423-0.
2017
AOU Città della Salute di Torino

Ribaldone DG; Astegiano M;

Gastric emptying and related symptoms in patients treated with buspirone, amitriptyline or clebopride: a "real world" study by 13C-octanoic Acid Breath Test. in Minerva medica / Minerva Med. 2017 Dec;108(6):489-495. doi: 10.23736/S0026-4806.17.05320-4. Epub 2017 Jul 12.
2017
AOU Città della Salute di Torino

Caviglia GP; Sguazzini C; Cisarò F; Ribaldone DG; Rosso C; Fagoonee S; Smedile A; Saracco GM; Astegiano M; Pellicano R;

Real time visualization may be advisable to exclude aspiration in patients undergoing capsule endoscopy examination. in Revista espanola de enfermedades digestivas / Rev Esp Enferm Dig. 2017 Dec;109(12):878-879. doi: 10.17235/reed.2017.5244/2017.
2017
AOU Città della Salute di Torino

Ribaldone DG; Bruno M; Solidoro P; De Angelis C;

On Inverse Association Between Helicobacter pylori Gastritis and Microscopic Colitis: The European Data. in Inflammatory bowel diseases / Inflamm Bowel Dis. 2016 Mar;22(3):E11-2. doi: 10.1097/MIB.0000000000000704.
2016
AO Cuneo
AOU Città della Salute di Torino

Simondi D; Astegiano M; Ribaldone DG; Pellicano R;

Pathogenesis of nephrotic syndrome after hematopoietic stem cell transplantations. in Minerva medica / Minerva Med. 2016 Jun;107(3):183-4.
2016
AOU Città della Salute di Torino

Dellepiane S; Ribaldone DG;

A preserved stratified pattern of the bowel wall 1 year after major surgery does not influence the surgical recurrence of Crohn's disease. in Irish journal of medical science / Ir J Med Sci. 2016 Feb;185(1):269-70. doi: 10.1007/s11845-015-1249-x. Epub 2015 Jan 13.
2016
AOU Città della Salute di Torino

Astegiano M; Resegotti A; Cammarota T; Ribaldone DG;

Adnexal localization of Crohn's disease and recurrent massive ovary cysts. in Revista espanola de enfermedades digestivas / Rev Esp Enferm Dig. 2016 Aug;108(8):525-6. doi: 10.17235/reed.2016.4301/2016.
2016
AOU Città della Salute di Torino

Ribaldone DG; Conti L; Resegotti A; Astegiano M;

Power Doppler sonography to predict the risk of surgical recurrence of Crohn's disease. in Journal of ultrasound / J Ultrasound. 2014 Jun 12;18(1):51-5. doi: 10.1007/s40477-014-0101-x. eCollection 2015 Mar.
2015
AOU Città della Salute di Torino

Sguazzini C; Adriani A; Pellicano R; Bresso F; Bonenti G; Debani P; Robotti D; Sarno A; Resegotti A; Cammarota T; Ribaldone DG; Reggiani S; Astegiano M;

Prevalence and prognostic value of hepatic histological alterations in patients with Crohn's disease. in Scandinavian journal of gastroenterology / Scand J Gastroenterol. 2015;50(12):1463-8. doi: 10.3109/00365521.2015.1064995. Epub 2015 Jul 2.
2015
AOU Città della Salute di Torino

Ribaldone DG; Garavagno M; Pellicano R; Bresso F; Fagoonee S; David E; Sapone N; Bonagura AG; Resegotti A; Astegiano M;

Glucose breath test and Crohn's disease: Diagnosis of small intestinal bacterial overgrowth and evaluation of therapeutic response. in Scandinavian journal of gastroenterology / Scand J Gastroenterol. 2015;50(11):1376-81. doi: 10.3109/00365521.2015.1050691. Epub 2015 May 19.
2015
AOU Città della Salute di Torino

Greco A; Caviglia GP; Brignolo P; Ribaldone DG; Reggiani S; Sguazzini C; Smedile A; Pellicano R; Resegotti A; Astegiano M; Bresso F;